Table 3.
Clinical outcome | Admission deficit | ||||||||
---|---|---|---|---|---|---|---|---|---|
Univariate logistic regression analysis | Linear regression | ||||||||
10 HU increase of TAI | OR (95% CI) | p | AUC | AIC | BIC | B (95% CI) | p | AIC | BIC |
Arterial phase | 1.21(1.041–1.414) | 0.01 | 0.62 | 296.1 | 302.9 | −0.87(−1.4 to − 0.34) | 0.002 | 903.0 | 909.7 |
Venous phase | 1.148(1.011–1.303) | 0.03 | 0.58 | 297.8 | 304.6 | −0.33(−0.78 to 0.11) | 0.139 | 910.9 | 917.7 |
Delayed phase | 1.046(0.919–1.19) | 0.50 | 0.53 | 302.3 | 309.1 | −0.10(−0.59 to 0.39) | 0.681 | 913.0 | 919.7 |
TiCTA | 1.153(1.021–1.301) | 0.02 | 0.60 | 297.0 | 303.8 | −0.44(−0.87 to − 0.01) | 0.044 | 909.0 | 915.8 |
TAI thrombus attenuation increase, OR odds ratio, aOR adjusted odds ratio, CI confidence interval, B linear regression coeficient, AUC area under the curve, AIC Akaike information criterion, BIC Bayesian information criterion, p significance value, HU Hounsfield unit, TiCTA time invariant computed tomography angiography; and italic p is significant at the 0.05 level